| 申请类型 | 申请号 | 药品名称 | 活性成分 | 活性成分中文 | 执行时间 | 持有公司 | 说明书 |
|---|---|---|---|---|---|---|---|
| BLA | 761262 | SKYRIZI | RISANKIZUMAB-RZAA | 查看 | 2022-06-21 | ABBVIE INC | 查看 |
| BLA | 761261 | XENPOZYME | OLIPUDASE ALFA-RPCP | 查看 | 2022-09-01 | GENZYME CORP | 查看 |
| BLA | 761244 | SPEVIGO | SPESOLIMAB-SBZO | 查看 | 2022-09-02 | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 查看 |
| BLA | 761235 | VABYSMO | FARICIMAB-SVOA | 查看 | 2022-02-01 | GENENTECH INC | 查看 |
| BLA | 761234 | OPDUALAG | NIVOLUMAB;RELATLIMAB-RMBW | 查看 | 2022-03-18 | BRISTOL MYERS SQUIBB | 查看 |
| BLA | 761231 | ALYMSYS | BEVACIZUMAB-MALY | 查看 | 2022-04-13 | AMNEAL PHARMS LLC | 查看 |
| BLA | 761228 | KIMMTRAK | TEBENTAFUSP-TEBN | 查看 | 2022-01-26 | IMMUNOCORE LTD | 查看 |
| BLA | 761224 | TEZSPIRE | TEZEPELUMAB-EKKO | 查看 | 2021-12-17 | ASTRAZENECA AB | 查看 |
| BLA | 761223 | JEMPERLI | DOSTARLIMAB-GXLY | 查看 | 2021-08-17 | GLAXOSMITHKLINE LLC | 查看 |
| BLA | 761216 | YUSIMRY | ADALIMUMAB-AQVH | 查看 | 2021-12-20 | COHERUS BIOSCIENCES INC | 查看 |
| BLA | 761215 | REZVOGLAR | INSULIN GLARGINE-AGLR | 查看 | 2021-12-19 | ELI LILLY CO | 查看 |
| BLA | 761210 | RYBREVANT | AMIVANTAMAB-VMJW | 查看 | 2021-12-23 | JANSSEN BIOTECH | 查看 |
| BLA | 761210 | RYBREVANT | AMIVANTAMAB-VMJW | 查看 | 2021-05-21 | JANSSEN BIOTECH | 查看 |
| BLA | 761208 | TIVDAK | TISOTUMAB VEDOTIN-TFTV | 查看 | 2021-09-20 | SEAGEN | 查看 |
| BLA | 761202 | BYOOVIZ | RANIBIZUMAB-NUNA | 查看 | 2022-06-13 | SAMSUNG BIOEPIS CO LTD | 查看 |
| BLA | 761202 | BYOOVIZ | RANIBIZUMAB-NUNA | 查看 | 2021-09-20 | SAMSUNG BIOEPIS CO LTD | 查看 |
| BLA | 761201 | SEMGLEE | INSULIN GLARGINE-YFGN | 查看 | 2021-07-28 | MYLAN PHARMS INC | 查看 |
| BLA | 761197 | SUSVIMO | RANIBIZUMAB | 查看 | 2022-04-20 | GENENTECH INC | 查看 |
| BLA | 761197 | SUSVIMO | RANIBIZUMAB | 查看 | 2021-10-25 | GENENTECH INC | 查看 |
| BLA | 761196 | ZYNLONTA | LONCASTUXIMAB TESIRINE-LPYL | 查看 | 2021-04-23 | ADC Therapeutics SA | 查看 |
